Extracellular matrix binding mixed micelles for drug delivery applications

Conlin P. O'Neil, André J. van der Vlies, Diana Velluto, Christine Wandrey, Davide Demurtas, Jacques Dubochet, Jeffrey A. Hubbell

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

We present the formation of collagen-binding mixed micelles and their potential suitability to deliver therapeutic drugs to the vessel wall. We modified poly(ethylene oxide)-bl-poly(propylene oxide)-bl-poly(ethylene oxide) (Pluronic F-127) to display sulfate groups on the terminus of the PEO block to act as a heparin mimics and bind to collagen in the extracellular matrix. This functionalized macroamphiphile was incorporated into a mixed micelle with poly(propylene sulfide)-bl-poly(ethylene oxide), a macroamphiphile that demonstrates improved micellar stability relative to Pluronic F-127 micelles. The mixed micelles were examined using analytical ultracentrifugation, dynamic light scattering, transmission electron microscopy, and measures of the critical micellar concentration using surface tensiometry. Encapsulation and in vitro release of Sirolimus, an immunosuppressant drug of interest in coronary artery treatment, was considered as an example. Mixed micelles with the sulfate functionality demonstrated enhanced binding to collagen I coated surfaces, suggestive of the potential for binding to the extracellular milieu.

Original languageEnglish
Pages (from-to)146-151
Number of pages6
JournalJournal of Controlled Release
Volume137
Issue number2
DOIs
StatePublished - Jul 20 2009
Externally publishedYes

Fingerprint

Micelles
Extracellular Matrix
Ethylene Oxide
Poloxamer
Pharmaceutical Preparations
Collagen
Sulfates
Ultracentrifugation
Sirolimus
Immunosuppressive Agents
Transmission Electron Microscopy
Heparin
Coronary Vessels

Keywords

  • Block copolymers
  • Drug delivery
  • Extracellular matrix
  • Mixed micelles
  • Sirolimus

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

O'Neil, C. P., van der Vlies, A. J., Velluto, D., Wandrey, C., Demurtas, D., Dubochet, J., & Hubbell, J. A. (2009). Extracellular matrix binding mixed micelles for drug delivery applications. Journal of Controlled Release, 137(2), 146-151. https://doi.org/10.1016/j.jconrel.2009.03.013

Extracellular matrix binding mixed micelles for drug delivery applications. / O'Neil, Conlin P.; van der Vlies, André J.; Velluto, Diana; Wandrey, Christine; Demurtas, Davide; Dubochet, Jacques; Hubbell, Jeffrey A.

In: Journal of Controlled Release, Vol. 137, No. 2, 20.07.2009, p. 146-151.

Research output: Contribution to journalArticle

O'Neil, CP, van der Vlies, AJ, Velluto, D, Wandrey, C, Demurtas, D, Dubochet, J & Hubbell, JA 2009, 'Extracellular matrix binding mixed micelles for drug delivery applications', Journal of Controlled Release, vol. 137, no. 2, pp. 146-151. https://doi.org/10.1016/j.jconrel.2009.03.013
O'Neil CP, van der Vlies AJ, Velluto D, Wandrey C, Demurtas D, Dubochet J et al. Extracellular matrix binding mixed micelles for drug delivery applications. Journal of Controlled Release. 2009 Jul 20;137(2):146-151. https://doi.org/10.1016/j.jconrel.2009.03.013
O'Neil, Conlin P. ; van der Vlies, André J. ; Velluto, Diana ; Wandrey, Christine ; Demurtas, Davide ; Dubochet, Jacques ; Hubbell, Jeffrey A. / Extracellular matrix binding mixed micelles for drug delivery applications. In: Journal of Controlled Release. 2009 ; Vol. 137, No. 2. pp. 146-151.
@article{6b8a8fc954714cf8a653f5e5529205c7,
title = "Extracellular matrix binding mixed micelles for drug delivery applications",
abstract = "We present the formation of collagen-binding mixed micelles and their potential suitability to deliver therapeutic drugs to the vessel wall. We modified poly(ethylene oxide)-bl-poly(propylene oxide)-bl-poly(ethylene oxide) (Pluronic F-127) to display sulfate groups on the terminus of the PEO block to act as a heparin mimics and bind to collagen in the extracellular matrix. This functionalized macroamphiphile was incorporated into a mixed micelle with poly(propylene sulfide)-bl-poly(ethylene oxide), a macroamphiphile that demonstrates improved micellar stability relative to Pluronic F-127 micelles. The mixed micelles were examined using analytical ultracentrifugation, dynamic light scattering, transmission electron microscopy, and measures of the critical micellar concentration using surface tensiometry. Encapsulation and in vitro release of Sirolimus, an immunosuppressant drug of interest in coronary artery treatment, was considered as an example. Mixed micelles with the sulfate functionality demonstrated enhanced binding to collagen I coated surfaces, suggestive of the potential for binding to the extracellular milieu.",
keywords = "Block copolymers, Drug delivery, Extracellular matrix, Mixed micelles, Sirolimus",
author = "O'Neil, {Conlin P.} and {van der Vlies}, {Andr{\'e} J.} and Diana Velluto and Christine Wandrey and Davide Demurtas and Jacques Dubochet and Hubbell, {Jeffrey A.}",
year = "2009",
month = "7",
day = "20",
doi = "10.1016/j.jconrel.2009.03.013",
language = "English",
volume = "137",
pages = "146--151",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - Extracellular matrix binding mixed micelles for drug delivery applications

AU - O'Neil, Conlin P.

AU - van der Vlies, André J.

AU - Velluto, Diana

AU - Wandrey, Christine

AU - Demurtas, Davide

AU - Dubochet, Jacques

AU - Hubbell, Jeffrey A.

PY - 2009/7/20

Y1 - 2009/7/20

N2 - We present the formation of collagen-binding mixed micelles and their potential suitability to deliver therapeutic drugs to the vessel wall. We modified poly(ethylene oxide)-bl-poly(propylene oxide)-bl-poly(ethylene oxide) (Pluronic F-127) to display sulfate groups on the terminus of the PEO block to act as a heparin mimics and bind to collagen in the extracellular matrix. This functionalized macroamphiphile was incorporated into a mixed micelle with poly(propylene sulfide)-bl-poly(ethylene oxide), a macroamphiphile that demonstrates improved micellar stability relative to Pluronic F-127 micelles. The mixed micelles were examined using analytical ultracentrifugation, dynamic light scattering, transmission electron microscopy, and measures of the critical micellar concentration using surface tensiometry. Encapsulation and in vitro release of Sirolimus, an immunosuppressant drug of interest in coronary artery treatment, was considered as an example. Mixed micelles with the sulfate functionality demonstrated enhanced binding to collagen I coated surfaces, suggestive of the potential for binding to the extracellular milieu.

AB - We present the formation of collagen-binding mixed micelles and their potential suitability to deliver therapeutic drugs to the vessel wall. We modified poly(ethylene oxide)-bl-poly(propylene oxide)-bl-poly(ethylene oxide) (Pluronic F-127) to display sulfate groups on the terminus of the PEO block to act as a heparin mimics and bind to collagen in the extracellular matrix. This functionalized macroamphiphile was incorporated into a mixed micelle with poly(propylene sulfide)-bl-poly(ethylene oxide), a macroamphiphile that demonstrates improved micellar stability relative to Pluronic F-127 micelles. The mixed micelles were examined using analytical ultracentrifugation, dynamic light scattering, transmission electron microscopy, and measures of the critical micellar concentration using surface tensiometry. Encapsulation and in vitro release of Sirolimus, an immunosuppressant drug of interest in coronary artery treatment, was considered as an example. Mixed micelles with the sulfate functionality demonstrated enhanced binding to collagen I coated surfaces, suggestive of the potential for binding to the extracellular milieu.

KW - Block copolymers

KW - Drug delivery

KW - Extracellular matrix

KW - Mixed micelles

KW - Sirolimus

UR - http://www.scopus.com/inward/record.url?scp=67349175012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349175012&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2009.03.013

DO - 10.1016/j.jconrel.2009.03.013

M3 - Article

VL - 137

SP - 146

EP - 151

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 2

ER -